Virginia Retirement Systems’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-24,217
Closed -$313K – 1025
2025
Q4
$313K Buy
24,217
+3,350
+16% +$43K ﹤0.01% 841
2025
Q3
$270K Buy
+20,867
New +$279K ﹤0.01% 860
2021
Q2
– Sell
-5,500
Closed -$727K – 1107
2021
Q1
$727K Sell
5,500
-4,600
-46% -$728K 0.01% 777
2020
Q4
$1.75M Sell
10,100
-7,600
-43% -$1.04M 0.02% 434
2020
Q3
$1.97M Buy
17,700
+1,400
+9% +$112K 0.02% 377
2020
Q2
$967K Sell
16,300
-2,200
-12% -$145K 0.01% 570
2020
Q1
$1.25M Buy
18,500
+11,600
+168% +$917K 0.02% 480
2019
Q4
$581K Buy
6,900
+800
+13% +$64.6K 0.01% 887
2019
Q3
$456K Buy
+6,100
New +$488K 0.01% 923

Other funds holding NVCR

Virginia Retirement Systems's NVCR Position: Q1 2026 in Review

Virginia Retirement Systems sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 24,217 shares — an estimated $313K sold.

Virginia Retirement Systems first reported a position in NVCR in Q3 2019 and held it in 9 quarters. The position peaked at $1.97M in Q3 2020. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Virginia Retirement Systems reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Virginia Retirement Systems sold 24,217 NovoCure shares in Q1 2026, an estimated $313K.
  • Virginia Retirement Systems first reported a position in NovoCure in Q3 2019 and held it in 9 quarters.
  • Virginia Retirement Systems's NovoCure position peaked at $1.97M in Q3 2020.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Virginia Retirement Systems's 13F filing for Q1 2026, filed 25 Aug 2026.